Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: Therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells

Diabetes

Volumn 53, Issue 9, 2004, Pages 2412-2419

  Seki, Masaaki ^a,b   Tanaka, Takayuki ^a,b   Nawa, Hiroyuki ^a   Usui, Tomoaki ^b   Fukuchi, Takeo ^b   Ikeda, Kazuhito ^c   Abe, Haruki ^b   Takei, Nobuyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NEUROTROPHIN; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTRAOCULAR DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RETINA AMACRINE CELL; RETINA DISEASE; RETINA NEUROPATHY; STREPTOZOCIN DIABETES;

AMACRINE CELLS; ANIMALS; ANTIBODIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOPAMINE; MALE; NEUROGLIA; NEURONS; NEUROTROPHIN 3; RATS; RATS, WISTAR; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 4344599833     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.9.2412     Document Type: Article

References (50)

1. Lieth E, Gardner TW, Barber AJ, Antonetti DA, Penn State Retina Research Group: Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:1-2, 2000
2. Nishimura C, Kuriyama K: Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes. J Neurochem 45:448-455, 1985
3. Northington FK, Hamill RW, Banerjee SP: Dopamine-stimulated adenylate cyclase and tyrosine hydroxylase in diabetic rat retina. Brain Res 337:151-154, 1985
4. Fernstrom MH, Volk EA, Fernstrom JD, Iuvone PM: Effect of tyrosine administration on dopa accumulation in light- and dark-adapted retinas from normal and diabetic rats. Life Sci 39:2049-2057, 1986
5. Hammes HP, Federoff HJ, Brownlee M: Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1:527-534, 1995
6. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 102:783-791, 1998
7. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy: Penn State Retina Research Group. Diabetes 47:815-820, 1998
8. Li Q, Puro DG: Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Invest Ophthalmol Vis Sci 43:3109-3116, 2002
9. Shirao Y, Kawasaki K: Electrical responses from diabetic retina. Prog Retin Eye Res 17:59-76, 1998
10. Lewin GR, Barde YA: Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317, 1996
11. Seki M, Nawa H, Fukuchi T, Abe H, Takei N: BDNF is upregulated by postnatal development and visual experience: quantitative and immunohistochemical analyses of BDNF in the rat retina. Invest Ophthalmol Vis Sci 44:3211-3218, 2003
12. Johnson JE, Barde YA, Schwab M, Thoenen H: Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 6:3031-3038, 1986
13. Kido N, Tanihara H, Honjo M, Inatani M, Tatsuno T, Nakayama C, Honda Y: Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death. Brain Res 884:59-67, 2000
14. Cusato K, Bosco A, Linden R, Reese BE: Cell death in the inner nuclear layer of the retina is modulated by BDNF. Brain Res Dev Brain Res 139:325-330, 2002
15. Cellerino A, Pinzon-Duarte G, Carroll P, Kohler K: Brain-derived neurotrophic factor modulates the development of the dopaminergic network in the rodent retina. J Neurosci 18:3351-3362, 1998
16. Gagne J, Milot M, Gelinas S, Lahsaini A, Trudeau F, Martinoli MG, Massicotte G: Binding properties of glutamate receptors in streptozotocin- induced diabetes in rats. Diabetes 46:841-846, 1997
17. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ: Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 91:1632-1636, 1994
18. Takei N, Kawamura M, Hara K, Yonezawa K, Nawa H: Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J Biol Chem 276:42818-42825, 2001
19. Hatanaka H, Arimatsu Y: Monoclonal antibodies to tyrosine hydroxylase from rat pheochromocytoma PC12h cells with special reference to nerve growth factor-mediated increase of the immunoprecipitable enzymes. Neurosci Res 1:253-263, 1984
20. Iwasaki Y, Nishiyama H, Suzuki K, Koizumi S: Sequential cis/trans autophosphorylation in TrkB tyrosine kinase. Biochemistry 36:2694-700, 1997
21. Nawa H, Carnahan J, Gall C: BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur J Neurosci 7:1527-1535, 1995
22. Narisawa-Saito M, Nawa H: Differential regulation of hippocampal neurotrophins during aging in rats. J Neurochem 67:1124-1131, 1996
23. Seki M, Nawa H, Morioka T, Fukuchi T, Oite T, Abe H, Takei N: Establishment of a novel enzyme-linked immunosorbent assay for Thy-1: quantitative assessment of neuronal degeneration. Neurosci Lett 329:185-188, 2002
24. Imai C, Sugai T, Iritani S, Niizato K, Nakamura R, Makifuchi T, Kakita A, Takahashi H, Nawa H: A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients. Neurosci Lett 305:185-188, 2001
25. Vecino E, Ugarte M, Nash MS, Osborne NN: NMDA induces BDNF expression in the albino rat retina in vivo. Neuroreport 10:1103-1106, 1999
26. Versaux-Botteri C, Nguyen-Legros J: An improved method for tyrosine hydroxylase immunolabeling of catecholamine cells in whole mounted rat retina. J Histochem Cytochem 34:743-747, 1986
27. Perry VH, Morris RJ, Raisman G: Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol 13:809-824, 1984
28. Politi LE, Rotstein NP, Salvador G, Giusto NM, Insua MF: Insulin-like growth factor-I is a potential trophic factor for amacrine cells. J Neurochem 76:1199-1211, 2001
29. Shires TK, Braddock KJ, Pulido JS: Insulin in the vitreous of the normal and streptozotocin-induced diabetic rat. Peptides 13:671-675, 1992
30. Reiter CE, Sandirasegarane L, Wolpert EB, Klinger M, Simpson IA, Barber AJ, Antonetti DA, Kester M, Gardner TW: Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab 285:E763-E774, 2003
31. Larabi Y, Dahmani Y, Gernigon T, Nguyen-Legros J: Tyrosine hydroxylase immunoreactivity in the retina of the diabetic sand rat Psammomys obesus. J Hirnforsch 32:525-531, 1991
32. Nakamura M, Barber AJ, Antonetti DA, LaNoue KF, Robinson KA, Buse MG, Gardner TW: Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem 276:43748-43755, 2001
33. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232, 1991
34. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR: Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 64:1231-1237, 1995
35. Nitta A, Murai R, Suzuki N, Ito H, Nomoto H, Katoh G, Furukawa Y, Furukawa S: Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 24:695-701, 2002
36. Duan W, Lee J, Guo Z, Mattson MP: Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci 16:1-12, 2001
37. Lindholm D, Castren E, Berzaghi M, Blochl A, Thoenen H: Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain: implications for neuronal plasticity. J Neurobiol 25:1362-1372, 1994
38. Takei N, Tanaka O, Endo Y, Lindholm D, Hatanaka H: BDNF and NT-3 but not CNTF counteract the Ca2+ ionophore-induced apoptosis of cultured cortical neurons: involvement of dual pathways. Neuropharmacology 38:283-288, 1999
39. Kaplan DR, Miller FD: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391, 2000
40. Feng L, Wang CY, Jiang H, Oho C, Mizuno K, Dugich-Djordjevic M, Lu B: Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 66:62-70, 1999
41. Yamada M, Tanabe K, Wada K, Shimoke K, Ishikawa Y, Ikeuchi T, Koizumi S, Hatanaka H: Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons. J Neurochem 78:940-951, 2001
42. Yamada M, Ohnishi H, Sano S, Nakatani A, Ikeuchi T, Hatanaka H: Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem 272:30334-30339, 1997
43. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W, Kasuga M, Taiji M, Noguchi H: The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 44:555-566, 2001
44. Cellerino A, Kohler K: Brain-derived neurotrophic factor/neurotrophin-4 receptor TrkB is localized on ganglion cells and dopaminergic amacrine cells in the vertebrate retina. J Comp Neurol 386:149-160, 1997
45. Nakagawa T, Tsuchida A, Itakura Y, Nonomura T, Ono M, Hirota F, Inoue T, Nakayama C, Taiji M, Noguchi H: Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49:436-444, 2000
46. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ: Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial: rhNGF Clinical Investigator Group. JAMA 284:2215-2221, 2000
47. Wellmer A, Misra VP, Sharief MK, Kopelman PG, Anand P: A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. J Peripher Nerv Syst 6:204-210, 2001
48. Pardridge WM: Neurotrophins, neuroprotection and the blood-brain barrier. Curr Opin Investig Drugs 3:1753-1757, 2002
49. Nitta A, Ito M, Fukumitsu H, Ohmiya M, Ito H, Sometani A, Nomoto H, Furukawa Y, Furukawa S: 4-methylcatechol increases brain-derived neurotrophic factor content and mRNA expression in cultured brain cells and in rat brain in vivo. J Pharmacol Exp Ther 291:1276-1283, 1999
50. Drasd N, Chiti Z, Owens DR, North RV: Effect of darkness on inner retinal hypoxia in diabetes. Lancet 359:2251-2253, 2002